Validation of L19-conjugated gold nanoparticles for V targeting: a novel approach to image progressive atherosclerotic lesions in a transgenic mouse mode

17 April 2026 (16:10 - 17:10)
Organised by: Logo
Congress Presentation Part of: Extracellular vesicles and nanoparticles in vascular disease Biomarkers Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

ESC 365 is supported by

ESC 365 is supported by